Active

Inno Pharma

Switched

BE0762694073

Rechtspersoon Private limited company 1 establishment

Rijksweg 17, 2870 Puurs-Sint-Amands Vervaardiging van farmaceutische grondstoffen

Active for

5 year, 7 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -66

▼ 3% vs 2024

Profit

Caution

€ -830

▲ 2% vs 2024

Debts

High

€ 3,200

▲ 113% vs 2024

Inno Pharma from Puurs-Sint-Amands, company number BE0762694073, closed financial year 2025 with a result of € -830 after tax. For that financial year Inno Pharma recorded a gross margin of € -66 and equity of € -1,955. Compared with financial year 2024, the result moved from € -849 to € -830. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What happened at Inno Pharma?

What happened at Inno Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 830. Source: NBB ↗
  • New establishment in Puurs-Sint-Amands. KBO
  • Bart Peeters became a director. NBB
  • Creafund NV became a director. NBB
  • Dominique Van Gucht became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 2,568 loss in 2022 to € 830 loss in 2025.

A new publication or filing at Inno Pharma? We notify you, reason included.

Follow Inno Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Bart Peeters
Dominique Van Gucht

Behind Inno Pharma are Bart Peeters, Creafund NV and Dominique Van Gucht. The same people are also behind Purna Pharmaceuticals, FHP, Bart M.J. Peeters, DIRESCO and COEMAN PACKAGING.

See the full network in the app

Directors

According to the 2025 annual accounts

Bart Peeters

Director

Also active at: Purna Pharmaceuticals, FHP, Bart M.J. Peeters

since 2021

Creafund NV

Director · represented by Ruth De Wulf

Also active at: DIRESCO, COEMAN PACKAGING, CREALOAN +16 more

since 2021

Dominique Van Gucht

Director

Also active at: FHP

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Rijksweg 17

2870 Puurs-Sint-Amands

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0762.694.073
VAT number
BE 0762.694.073
Registered office
Rijksweg 17, 2870 Puurs-Sint-Amands
Names & denominations
Inno Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
29 January 2021
Peppol
Active · Active since 27 Mar 2026
Contact
bpt@purna.be
Activities · NACE

Vervaardiging van farmaceutische grondstoffen

Frequently asked questions

What is the enterprise number of Inno Pharma?
The enterprise number of Inno Pharma is BE0762694073.
What is the address of Inno Pharma?
The registered office of Inno Pharma is located at Rijksweg 17, 2870 Puurs-Sint-Amands.
When was Inno Pharma founded?
Inno Pharma was founded on 29 January 2021.
What is the main activity of Inno Pharma?
The main activity of Inno Pharma is "Vervaardiging van farmaceutische grondstoffen" (NACE code 21100).
Does Inno Pharma have a website?
No website is currently known for Inno Pharma.
How much profit did Inno Pharma make in 2025?
Inno Pharma recorded a loss after taxes of € 830 in financial year 2025.
What is the revenue of Inno Pharma?
As a small company, Inno Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -66.
Where can I find the annual accounts of Inno Pharma?
Inno Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Inno Pharma?
According to the 2025 annual accounts, the directors of Inno Pharma are: Bart Peeters, Creafund NV, Dominique Van Gucht.
Who owns Inno Pharma?
Behind Inno Pharma are Bart Peeters, Creafund NV and Dominique Van Gucht. The same people are also behind Purna Pharmaceuticals, FHP, Bart M.J. Peeters, DIRESCO and COEMAN PACKAGING.